Version 5.4
Homo sapiens Protein: GABRA1
Summary
InnateDB Protein IDBP-480212.3
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol GABRA1
Protein Name gamma-aminobutyric acid (GABA) A receptor, alpha 1
Synonyms ECA4; EIEE19; EJM; EJM5;
Species Homo sapiens
Ensembl Protein ENSP00000430507
InnateDB Gene IDBG-56393 (GABRA1)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 4 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
Experimentally validated
Total 4 [view]
Protein-Protein 4 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 3 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0004890 GABA-A receptor activity
GO:0005230 extracellular ligand-gated ion channel activity
Biological Process
GO:0006810 transport
GO:0007165 signal transduction
GO:0034220 ion transmembrane transport
Cellular Component
GO:0016020 membrane
Protein Structure and Domains
PDB ID
InterPro IPR001390 Gamma-aminobutyric-acid A receptor, alpha subunit
IPR006202 Neurotransmitter-gated ion-channel ligand-binding
PFAM PF02931
PRINTS PR01079
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL E5RJS3
UniProt Splice Variant
Entrez Gene 2554
UniGene Hs.595114
RefSeq
HUGO HGNC:4075
OMIM 137160
CCDS
HPRD 00662
IMGT
EMBL AC021079 AC108130
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca